Clinical Trials Recruitment
"The staff of the Clinical Trials Centre were friendly and confident and I knew I was getting the best possible care," Mr Maurie Richards, Clinical Trials participant.
Volunteering for a research trial
Clinical trials require the participation of volunteers. Without volunteers the advancement of new medications, diagnostics and surgical techniques could be further away.
Benefits to volunteering include:
- Comprehensive medical care free of charge
- Access to new and emerging treatments that may improve your quality of life
- Potential to help others with similar conditions in the future
- More active role in treatment
Your health, safety and privacy are of the utmost importance to us. The risks and benefits associated with joining a clinical trial will be explained before joining so that you can make an informed choice.
There are no costs associated with taking part in a trial. All treatment and tests are free. Volunteers are reimbursed for travel and parking expenses incurred as a result of participating.
There are two kinds of volunteers we look for:
- Healthy participants
- Participants who have been diagnosed with a disease for which a new treatment is being developed
Click here to fill out a clinical survey so you can be notified of clinical trials that may be of interest to you.
Current trials seeking volunteers
The Institute is currently seeking volunteers for the following research trials:
-
ARTHRITIS -
ANTI-BAFF - A new treatment for sufferers of Rheumatoid Arthritis who are currently treated with Methotrexate.
-
ASBESTOS -
GUARD - The aim of this study is to build a new national biospecimen resource for asbestos related diseases
-
BRAIN ANEURYSM -
ARUBA - The objective of this study is to determine whether medical management improves long-term outcomes of patients with unruptured brain arteriovenous malformations compared to interventional therapy such as neurosurgery, radiotherapy and endovascular procedures
-
CANCER -
SNAC II - This study compares two operations for detecting cancer cells in the lymph nodes of women with breast cancer
-
CARDIOVASCULAR -
FREEDOM - The purpose of this study is to compare two different methods of treatment for participants with diabetes and coronary artery disease in more than one heart vessel: coronary artery bypass graft surgery and medication-eluting stents
ARISTOTLE - This study is comparing a new medication to standard treatment (warfarin) in the prevention of stroke
AVERROES - This study is testing a new medication compared to aspirin for the prevention of stroke in patients with atrial fibrillation for those people who are unable to take warfarin
ROCKET - This study is comparing a new medication to standard treatment (warfarin) in the prevention of stroke
STABILITY - This new drug will be trialled in people who have had a heart attack and aims to reduce a reoccurrence.
-
HYPERTENSION -
PATENT 1 - A new drug for people with pulmonary hypertension who have not received treatment previously.
PATENT 2 - This will be an extension of Patent 1 study and eligibility is limited to those who participated in Patent 1.
CHEST 1 - This study will assess the efficacy and safety of different doses of a new drug riociguat, given orally to patients with Chronic Pulmonary Hypertension.
CHEST 2 - A long term extension of the trial Chest 1
-
MULTIPLE SCLEROSIS -
CAMM323 - This study is for people with MS who have not received prior treatment other than steroids for their MS. The purpose of the study is to compare the effect of a new medication to a currently available medication for the treatment of MS
CAMM324 - This study is for people with MS who have relapsed on treatment. The purpose of the study is to compare the effect of a new medication to a currently available medication for the treatment of MS
-
WOMEN'S HEALTH -
MIRENA - A study to compare two medications, and evaluate their effectiveness in reducing menstrual bleeding associated with the use of the Mirena intra-uterine device.
If you would like to volunteer for any of these clinical trials please click here. For other questions or to find out more information please call The Wesley Research Institute Clinical Trials Centre on 07 3232 7920 or send an email to clinicaltrials@wesleyresearch.com.au.
